Home › Funds › Spruce Street Capital LP › ATOS

Spruce Street Capital LP position in ATOS

ATTOVIA THERAPEUTICS INC · Health Care

Spruce Street Capital LP reported holding 228,295 shares of ATOS (ATTOVIA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$3.9M, representing 0.62% of its reported portfolio and ranking #31 among its reported holdings. Spruce Street Capital LP first reported this position in Q3 2026.

Latest position (Q3 2026)228.29K sh
Reported value held$3.91M
Portfolio Weight0.62%
First reportedQ3 2026
Last changeNew
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Spruce Street Capital LP's ATOS position evolved

Spruce Street Capital LP first disclosed a stake in ATOS in Q3 2026 at 228,295 shares (US$3.9M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 228.29K $3.91M New

About ATOS and 13F data

ATOS (ATTOVIA THERAPEUTICS INC) is a Health Care company. 29 other funds we track also report a position in ATOS — the largest reported positions include Sanofi (US$18.6M), Vivo Capital, LLC (US$5.1M), Kalehua Capital Management LLC (US$3.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ATOS

All ATOS fund holders →

FAQ

How long has Spruce Street Capital LP held ATOS?

Spruce Street Capital LP has disclosed ATOS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Spruce Street Capital LP's current position in ATOS?

As of Q3 2026, Spruce Street Capital LP holds 228.29K shares of ATOS (ATTOVIA THERAPEUTICS INC), valued at $3.91M, representing 0.62% of its reported portfolio and ranking #31.

Has Spruce Street Capital LP been buying or selling ATOS?

In the latest 13F filing (Q3 2026), Spruce Street Capital LP newly opened its position in ATOS.

Which other funds hold ATOS?

Other major institutional holders of ATOS include Sanofi, Vivo Capital, LLC, Kalehua Capital Management LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.